HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2010-02-15Clinical Trial Update: Lopinavir/Ritonavir or Efavirenz as First-line Antiretroviral Therapy [Phase 4]
A Phase 4 clinical trial evaluating first-line antiretroviral therapy using Lopinavir/ritonavir versus Efavirenz for HIV infection; the stud…
-
FDA approval · 2010-02-10FDA Approved: NORVIR — Original Application (AbbVie Inc.)
FDA approved NORVIR (ritonavir) under its original application with AbbVie, establishing ritonavir's use as part of antiretroviral therapy f…
-
CLINICAL_TRIALS trial_result · 2010-02-10Clinical Trial Update: Maraviroc (Celsentri) With Raltegravir and Darunavir/Ritonavir for the Treatment of Triple Class Failure in Adult HIV-1 Infected Patients [Phase 4]
A Phase 4 clinical trial is evaluating maraviroc in combination with raltegravir and darunavir/ritonavir for adults with HIV-1 who have trip…
-
CLINICAL_TRIALS trial_result · 2010-02-10Clinical Trial Update: Effect of Soluble Fiber on Hypertriglyceridemia and Immune Profile in HIV-positive Individuals. [NA]
A completed clinical trial evaluated the impact of soluble fiber on triglyceride levels and immune profile in HIV-positive individuals.
-
CLINICAL_TRIALS trial_result · 2010-02-08Clinical Trial Update: A Pilot Study of the Effect of Minocycline on Cerebrospinal Fluid HIV-1 Infection
This completed pilot clinical trial examined the effect of minocycline on HIV-1 infection in cerebrospinal fluid.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-02-05Clinical Trial Update: A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen [Phase 3]
A Phase IIIb study comparing two boosted protease inhibitor-based HAART regimens in HIV-infected patients experiencing their first virologic…
-
CLINICAL_TRIALS trial_result · 2010-02-05Clinical Trial Update: Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir [Phase 3]
Phase 3 trial evaluating switching HIV patients with undetectable viral load and abnormal lipids to the fixed-dose combination of atazanavir…
-
CLINICAL_TRIALS trial_result · 2010-02-04Clinical Trial Update: Raltegravir Treatment in Patients Failing Highly Active Antiretroviral Therapy (HAART) in Denmark
Clinical trial update on raltegravir treatment for HIV-infected patients failing HAART in Denmark; the study has completed.
-
CLINICAL_TRIALS trial_result · 2010-02-04Clinical Trial Update: DDI HV (ATV - Merck) [Phase 1]
Phase 1 clinical trial update for atazanavir (ATV) related to HIV infections; the study status is listed as completed.
-
CLINICAL_TRIALS trial_result · 2010-02-02Clinical Trial Update: Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 Patients [Phase 4]
A Phase 4 clinical trial evaluating a combination of tenofovir disoproxil fumarate and emtricitabine in HIV-1 patients has completed.
-
CLINICAL_TRIALS trial_result · 2010-02-01Clinical Trial Update: Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Administration When Coadministered With Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-Experienced Human Immunodeficiency Virus Type 1 Infected Subjects [Phase 3]
Phase 3 study comparing once-daily versus twice-daily lopinavir/ritonavir in ART-experienced HIV-1 infected subjects coadministered with nuc…
-
FDA approval · 2010-01-29FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) from AbbVie Inc.
-
FDA approval · 2010-01-29FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Kaletra (lopinavir/ritonavir) from AbbVie Inc.
-
CLINICAL_TRIALS trial_result · 2010-01-29Clinical Trial Update: The Impact of Short Message Services (SMS) on ARV Adherence in Western Kenya [NA]
This completed clinical trial evaluated whether SMS reminders could improve adherence to antiretroviral therapy in Western Kenya.
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: Antiviral Activity and Safety of Mifepristone at 2 Doses in HIV-1 Infected Subjects [Phase 2]
Phase 2 trial assessing antiviral activity and safety of two doses of mifepristone in HIV-1 infected subjects.
-
FDA approval · 2010-01-27FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
The FDA approved a supplemental application for Prezista (darunavir) from Janssen Products LP. The action updates the labeling/indication fo…
-
CLINICAL_TRIALS trial_result · 2010-01-26Clinical Trial Update: A Comparison of Virco®TYPE HIV-1 Testing Versus Expert Interpretation of Genotypic Results for Control of HIV-1 Replication [Phase 4]
Phase 4 trial comparing VircoTYPE HIV-1 testing with expert interpretation of genotypic results to control HIV infection.
-
FDA approval · 2010-01-22FDA Approved: REYATAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for Reyataz (atazanavir) from E.R. Squibb & Sons, L.L.C., approving the sponsor's requested chan…
-
CLINICAL_TRIALS trial_result · 2010-01-20Clinical Trial Update: Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks* [Phase 2]
Phase 2 safety and efficacy study of Bevirimat monotherapy in HIV treatment-experienced patients for 2 weeks has completed.
-
FDA approval · 2010-01-15FDA Approved: TRUVADA — Supplemental Application (Gilead Sciences, Inc)
The FDA approved a supplemental application for TRUVADA (emtricitabine and tenofovir disoproxil fumarate) submitted by Gilead Sciences, Inc.…
-
CLINICAL_TRIALS trial_result · 2010-01-15Clinical Trial Update: The Effect of Vitamin D and Calcium on Bone in Pediatric HIV [Phase 2, Phase 3]
Phase 2/3 trial completion evaluating vitamin D and calcium supplementation for bone density in pediatric HIV patients.
-
CLINICAL_TRIALS trial_result · 2010-01-13Clinical Trial Update: Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected Subjects [Phase 1]
Phase 1 pharmacokinetic study in HIV-infected subjects comparing once-daily darunavir/ritonavir with twice-daily and once-daily raltegravir …
-
CLINICAL_TRIALS research · 2010-01-12Clinical Trial Update: Patient Preference, Sleep Quality, and Anxiety/Depression: A Comparison of Raltegravir and Efavirenz [NA]
This clinical trial compares raltegravir and efavirenz in HIV patients, evaluating patient preference, sleep quality, and anxiety/depression…
-
CLINICAL_TRIALS trial_result · 2010-01-07Clinical Trial Update: Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study) [Phase 4]
This Phase 4 clinical trial update reports results from the INDUMA study evaluating induction–maintenance therapy with atazanavir in HIV-nai…
-
CLINICAL_TRIALS trial_result · 2010-01-07Clinical Trial Update: Study of UC-781 Vaginal Microbicide [Phase 1]
Phase 1 clinical trial evaluating UC-781 as a vaginal microbicide for HIV infection has completed.